|
Arshine Group Co.,Ltd.
|
Cimetidine is an oral medication belonging to the class of histamine H2 receptor antagonists. It is commonly used to treat conditions related to excess stomach acid production, such as acid reflux, gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome.
Cimetidine works by blocking the action of histamine on specific receptors in the stomach lining, which helps reduce the production of stomach acid. By decreasing acid secretion, the medication can alleviate symptoms like heartburn, indigestion, and stomach pain associated with conditions where excessive acid causes discomfort.
This medication is available in various forms, including tablets and oral suspensions, allowing for flexible dosing options to suit individual patient needs. Cimetidine is typically taken orally, and the dosage may vary depending on the specific condition being treated and the patient's medical history.
|
Product Name
|
Cimetidine
|
Batch NO.
|
C32112001
|
|
Quantity
|
250kg
|
Packaging
|
25kg/drum*10
|
|
Manufacture Date
|
Dec. 03, 2021
|
Expiry Date
|
Nov, 2024
|
|
Standard Basis
|
CP 2020
|
|
TEST
|
SPECIFICATIONS
|
RESULTS
|
|
Characteristics
|
White or almost white crystalline powder;
odorless.
|
white , crystalline powder; odorless.
|
|
Absorptivity
|
751～797
|
778.4
|
|
Identific-
ation
|
(1)
|
Conform
|
Conform
|
|
(2)
|
Conform
|
Conform
|
|
(3)
|
Conform to IR Reference map
|
Conform
|
|
Appearance of solution
|
Conform
|
Conform
|
|
Chorides
|
not more than 0.008%
|
Conform
|
|
Loss on drying
|
not more than 0.5%
|
0.17%
|
|
Residue on ignition
|
not more than 0.1%
|
0.060%
|
|
Heavy metals
|
not more than 10ppm
|
Conform
|
|
Related substances
|
Single impurity
Total impurities
|
not more than 0.2%
not more than 1.0%
|
Conform
Conform
|
|
Assay(dried basis)
|
not less than 99.0%
|
99.96%
|
|
Conclusion
|
Comply with CP 2020.
|
|
QC Review:
Date:
|
QA Approval:
Date:
|
|
Send Inquiry
|
Pharma Sources Insight June 2024: Globalization on the Go
